Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,000
Closed -$4.64M 6745
2025
Q4
$4.64M Buy
+50,000
New +$5.45M ﹤0.01% 3818
2017
Q2
Sell
-400
Closed -$24K 6855
2017
Q1
$24K Sell
400
-200
-33% -$12.4K ﹤0.01% 6473
2016
Q4
$38K Buy
600
+200
+50% +$12.1K ﹤0.01% 6458
2016
Q3
$22K Buy
400
+300
+300% +$14.4K ﹤0.01% 6728
2016
Q2
$4K Buy
+100
New +$4.22K ﹤0.01% 6941
2015
Q3
Sell
-400
Closed -$14K 7390
2015
Q2
$14K Sell
400
-700
-64% -$25.4K ﹤0.01% 7124
2015
Q1
$40K Sell
1,100
-600
-35% -$22.4K ﹤0.01% 6758
2014
Q4
$72K Buy
1,700
+1,300
+325% +$51.9K ﹤0.01% 6698
2014
Q3
$16K Sell
400
-600
-60% -$24K ﹤0.01% 7009
2014
Q2
$41K Sell
1,000
-700
-41% -$26.6K ﹤0.01% 6792
2014
Q1
$60K Buy
+1,700
New +$64.4K ﹤0.01% 6525
2013
Q4
Sell
-300
Closed -$13K 6723
2013
Q3
$13K Sell
300
-400
-57% -$16.4K ﹤0.01% 6466
2013
Q2
$30K Buy
+700
New +$29.9K ﹤0.01% 6144

Other funds holding ITRI

Goldman Sachs's ITRI Position: Q1 2026 in Review

Goldman Sachs reduced its Itron (ITRI) stake by 14% in Q1 2026, selling an estimated $7.68M and leaving 486,755 shares worth $43.6M. The position accounts for 0.01% of the portfolio, ranked #1689.

Goldman Sachs first reported a position in ITRI in Q2 2013 and has held it in 52 quarters since. The position peaked at $129M in Q2 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Goldman Sachs held 486,755 shares of Itron worth $43.6M as of Q1 2026.
  • Goldman Sachs sold 79,948 Itron shares in Q1 2026, an estimated $7.68M.
  • Itron made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1689 holding.
  • Goldman Sachs first reported a position in Itron in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Itron position peaked at $129M in Q2 2025.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.